Get the Stockscreener App
24.38
3.75%
0.8809
After Hours:
24.35
-0.0309
-0.13%
Virtus Lifesci Biotech Clinical Trials Etf stock is traded at $24.38, with a volume of 16,591.
It is up +3.75% in the last 24 hours and up +10.92% over the past month.
See More
Previous Close:
$23.50
Open:
$23.78
24h Volume:
16,591
Relative Volume:
0.51
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+7.40%
1M Performance:
+10.92%
6M Performance:
+21.78%
1Y Performance:
-10.35%
1-Day Range:
$23.69
$24.53
1-Week Range:
$22.82
$24.53
52-Week Range:
$13.42
$31.65
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Name
Virtus Lifesci Biotech Clinical Trials Etf
Sector
Industry
Phone
-
Address
-
Compare BBC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
24.38 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
319.55 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
647.24 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
650.47 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.52 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
576.06 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Latest News
2 High Risk ETFs That Aren’t Leveraged, Inverse, or Single-Stock - Investing.com
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
How to Take Advantage of moves in (BBC) - news.stocktradersdaily.com
(BBC) Trading Report - news.stocktradersdaily.com
(BBC) Trading Signals - news.stocktradersdaily.com
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
(BBC) Investment Analysis and Advice - news.stocktradersdaily.com
Wall Street Week Ahead - Seeking Alpha
Trend Tracker for (BBC) - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(BBC) Trading Advice - Stock Traders Daily
5 Top ETFs of Last Week - Yahoo Finance
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - Nasdaq
Pharma Stocks Look Cheap. Here's One Way to Invest. - The Globe and Mail
Long Term Trading Analysis for (BBC) - news.stocktradersdaily.com
The 5 Best Biotech ETFs of 2024 - ETF.com
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - CMC Markets
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
Best-Performing ETFs of Last Week - Nasdaq
Top and Flop Industry ETFs of Q3 - Nasdaq
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
ALPS’ Biotech ETF SBIO Week’s Top Performer - ETF Trends
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Zacks Investment Research
Biotech ETFs Are Making a Comeback - ETF Trends
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Zacks Investment Research
Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point - ETF Trends
Betting on Biotech Bear Market Expiration Date - ETF Trends
How to Pick a Biotech ETF - Investment U
Positioning for Biotech Bounceback - ETF Trends
Some Biotech Stocks Are Now Cheap - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
ETF Exchange: Latest ETF News & Insights | Pensions & Investments - Pensions & Investments
Finding Synergy With SPY - ETF.com
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Yahoo Finance
Want to Use ETFs to Play Biotech? Choose Wisely. - Barron's
More than Just COVID: Hot ETFs for Medical Breakthroughs - ETF Trends
Top Tech ETFs Right Now - Benzinga
Biotech ETFs Soar on Gilead-Immunomedics Deal - Yahoo Finance
Betting on Biotech With Utility Beyond Covid-19 - ETF Trends
A Healthcare ETF Could Benefit From Index Reshuffling - ETF Trends
ETF of the Week: Vanguard Total Stock Market ETF (VTI) - ETF Trends
5 Market-Beating Smart-Beta ETF Charts of 2019 - Yahoo Finance
ETF of the Week: ProShares's ONLN ETF - ETF Trends
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Financials Data
There is no financial data for Virtus Lifesci Biotech Clinical Trials Etf (BBC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.32%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):